Stocks Health care PALI
NASDAQ · Health carePalisade Bio, Inc. (PALI)
Palisade Bio, Inc. brought in $500K of revenue over the twelve months to June 30, 2026. It posted a net loss of $31.9M. At June 30, 2026 it held $125.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 10, 2026.
What Palisade Bio, Inc. does
Palisade Bio, Inc. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker PALI.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $0 | -$16.8M | -$0.30 | n/a |
| 2024 | $0 | -$14.4M | -$10.19 | -$12.2M |
| 2023 | $300K | -$12.3M | -$27.01 | -$11.1M |
| 2022 | $0 | -$14.3M | -$248.04 | -$13.4M |
| 2021 | n/a | -$26.6M | -$2,547.04 | -$14.8M |
| 2020 | $13.5K | -$10.3M | -$2,794.99 | -$4.8M |
Latest SEC filings
What Palisade Bio, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- August 10, 2026
- August 10, 2026Quarterly report 10-Q · period to June 30, 2026
- July 29, 2026Passive stake (5% or more) SCHEDULE 13G
- June 11, 2026
- June 10, 2026
- May 27, 2026Passive stake (5% or more) SCHEDULE 13G
- May 15, 2026Passive stake changed SCHEDULE 13G/A
- May 15, 2026Passive stake changed SCHEDULE 13G/A
Questions about PALI
What does Palisade Bio, Inc. do?
Palisade Bio, Inc. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker PALI.
Is Palisade Bio, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $31.9M on revenue of $500K.
How much revenue does Palisade Bio, Inc. make?
Over the twelve months to June 30, 2026 Palisade Bio, Inc. reported revenue of $500K.
When did Palisade Bio, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 10, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from August 21, 2026.
Similar companies
Follow PALI
Get an email when Palisade Bio, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow PALI: get an email when it filesWhere the numbers come from
Financial figures are the values Palisade Bio, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.